Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a non-randomized, clinical phase I/II basic science trial studying VSL#3 TM (450 Billion CFU twice daily for 8 weeks) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)
Change in Il-17 levels with probiotic administration
The trial was stopped because there was no evidence that the probiotic would benefit the patient.
…